Alzamend Neuro (ALZN) EBITDA (2020 - 2026)
Alzamend Neuro (ALZN) EBITDA from Jul 31, 2020 to Jan 31, 2026. The TTM Alzamend Neuro (ALZN) EBITDA is -$6.97M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Alzamend Neuro (ALZN) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +67.55% |
| 3 Years TTM | -23.27% |
| 5 Years TTM | +13.63% |
| All Time TTM | +3.81% |
Annual EBITDA change of Alzamend Neuro (ALZN)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$2.20M | -50.56% |
| 2025 | -$4.45M | -55.01% |
| 2024 | -$9.89M | -33.40% |
| 2023 | -$15M | +20.54% |
| 2022 | -$12M | +151.43% |
| 2021 | -$4.90M | +11.11% |
| 2020 | -$4.41M | N/A |